Amcor leads fragmented healthcare packaging market with 3% share

The global healthcare packaging market remains highly fragmented, with the top 10 players holding just 9% of revenue in 2024, according to The Business Research Company. Amcor led sales with a 3% share as packaging makers race to expand sterile, smart, and sustainable solutions for drug and device makers.

Why it matters: - Healthcare packaging sits at the center of drug stability, contamination prevention, patient convenience, and supply chain traceability. - The market’s low concentration gives specialized packaging makers room to win share through innovation, capacity expansions, and partnerships. - Growth in biologics, advanced drug delivery systems, and environmentally responsible materials is pushing buyers toward more technical packaging formats.

What happened: - The Business Research Company’s Healthcare Packaging Global Market Report 2026 said Amcor plc led global healthcare packaging sales in 2024 with a 3% market share. - The report said the top 10 players accounted for 9% of total market revenue in 2024. - The report identified a broad field of global packaging manufacturers and healthcare packaging specialists active in the market. - The report named Amcor plc, West Pharmaceutical Services Inc., Gerresheimer AG, Schott AG, AptarGroup Inc., Sealed Air Corporation, Berry Global Inc., Corning Incorporated, Constantia Flexibles Group, and Sonoco Products Company among the leading companies. - The report also listed major end users including Pfizer, Johnson & Johnson, Roche, Novartis, Merck, Sanofi, AstraZeneca, GlaxoSmithKline, AbbVie, Eli Lilly, Bristol Myers Squibb, Takeda, Boehringer Ingelheim, Novo Nordisk, Teva, Becton Dickinson, Medtronic, Siemens Healthineers, GE HealthCare, and Boston Scientific.

The details: - Amcor’s healthcare packaging business offers flexible packaging, pharmaceutical pouches, blister packaging, medical device packaging, and high-barrier packaging systems. - Those products support product protection, sterility assurance, regulatory compliance, and supply chain efficiency. - The report said market barriers remain moderate because of strict pharmaceutical packaging standards, sterility and contamination control requirements, material compatibility issues, and specialized manufacturing needs. - The report listed major raw material suppliers including Dow, LyondellBasell, ExxonMobil Chemical, SABIC, BASF, Covestro, INEOS, Eastman Chemical, Mitsubishi Chemical Group, Toray, Borealis, Westlake, Ardagh Group, Nihon Yamamura Glass, Saint-Gobain Life Sciences, DuPont, Celanese, Kuraray, and Evonik. - The report listed major wholesalers and distributors including Berlin Packaging, TricorBraun, Pipeline Packaging, SKS Bottle & Packaging, Kaufman Container, MJS Packaging, O.Berk, Freund Container & Supply, Bunzl Healthcare, Imperial Dade Industrial, Cole-Parmer, Thomas Scientific, Fisher Scientific Packaging, COMPASS Health Supply Logistics, Nexus Packaging, APG Packaging Group, and Matrix Packaging Solutions. - The report said major strategies include recyclable mono-material solutions, smart packaging technologies, high-barrier materials, strategic capacity expansions, and prefilled syringe and biologics packaging development.

Between the lines: - The fragmented structure means scale alone does not guarantee dominance in healthcare packaging. - Companies with sterile barrier expertise, quality systems, and global production networks appear better positioned as regulation and technical demands rise. - The market’s emphasis on sustainability and traceability suggests customers want packaging that does more than protect product. - Amcor’s 2024 lead and the small share held by the next-largest players underline how dispersed revenue remains across the category. - In April 2026, Amcor opened an advanced healthcare packaging coating facility in Malaysia with air-knife coating technology for coated medical paper used in sterile medical device packaging. - The facility’s precision coating, automated quality control, and integrated manufacturing are aimed at improving consistency and supporting Asia-Pacific commercialization.

What's next: - The report expects product innovation, strategic collaborations, and capacity expansion to strengthen leading companies’ positions. - Demand for advanced drug delivery systems, biologics packaging, patient-centric solutions, and environmentally responsible materials is likely to keep pressure on suppliers. - The Business Research Company said its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, market hotspot infographics, and updated graphics and tables. - The company also said it offers expanded research packages for market entry, competitor tracking, and supplier and distributor analysis.

The bottom line: - Healthcare packaging is still a crowded market, but sterile, sustainable, and traceable packaging capabilities are becoming the clearest paths to growth.